BOSTON SCIENTIFIC CORPORATION Proceeds from Stock Plans
BOSTON SCIENTIFIC CORPORATION (BSX) reported Proceeds from Stock Plans of $86.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockPlans · last filed 2026-08-03
- BOSTON SCIENTIFIC CORPORATION proceeds from stock plans for the quarter ending 2026-06-30 was $5.00M, a 84.38% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION proceeds from stock plans for the quarter ending 2026-03-31 was $81.00M, a 29.57% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION proceeds from stock plans for the quarter ending 2025-12-31 was $20.00M, a 28.57% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION proceeds from stock plans for the quarter ending 2025-09-30 was $115.00M, a 19.79% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION proceeds from stock plans for fiscal 2025 was $282.00M, a 22.61% increase from fiscal 2024.
- BOSTON SCIENTIFIC CORPORATION proceeds from stock plans for fiscal 2024 was $230.00M, a 26.37% increase from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION proceeds from stock plans for fiscal 2023 was $182.00M, a 33.82% increase from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION proceeds from stock plans for fiscal 2022 was $136.00M, a 23.64% increase from fiscal 2021.
| Period end | Proceeds from Stock Plans 3 month | Proceeds from Stock Plans 6 month | Proceeds from Stock Plans 9 month | Proceeds from Stock Plans 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $86.00M 10-Q · filed 2026-08-03 | $106.00M derived: sum of 3 quarters · filed 2026-08-03 | $221.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $81.00M 10-Q · filed 2026-05-01 | $101.00M derived: sum of 2 quarters · filed 2026-05-01 | $216.00M derived: sum of 3 quarters · filed 2026-05-01 | $248.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $135.00M derived: sum of 2 quarters · filed 2026-02-17 | $167.00M derived: sum of 3 quarters · filed 2026-08-03 | $282.00M 10-K · filed 2026-02-17 |
| 2025-09-30 | $115.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $147.00M derived: sum of 2 quarters · filed 2026-08-03 | $262.00M 10-Q · filed 2025-11-03 | $290.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $32.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $147.00M 10-Q · filed 2026-08-03 | $175.00M derived: sum of 3 quarters · filed 2026-08-03 | $271.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $115.00M 10-Q · filed 2026-05-01 | $143.00M derived: sum of 2 quarters · filed 2026-05-01 | $239.00M derived: sum of 3 quarters · filed 2026-05-01 | $265.00M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $28.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $124.00M derived: sum of 2 quarters · filed 2026-02-17 | $150.00M derived: sum of 3 quarters · filed 2026-02-17 | $230.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $96.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $122.00M derived: sum of 2 quarters · filed 2025-11-03 | $202.00M 10-Q · filed 2025-11-03 | $219.00M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $26.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $106.00M 10-Q · filed 2025-08-01 | $123.00M derived: sum of 3 quarters · filed 2026-02-17 | $198.00M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $80.00M 10-Q · filed 2025-05-01 | $97.00M derived: sum of 2 quarters · filed 2026-02-17 | $172.00M derived: sum of 3 quarters · filed 2026-02-17 | $199.00M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $92.00M derived: sum of 2 quarters · filed 2026-02-17 | $119.00M derived: sum of 3 quarters · filed 2026-02-17 | $182.00M 10-K · filed 2026-02-17 |
| 2023-09-30 | $75.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $102.00M derived: sum of 2 quarters · filed 2024-11-01 | $165.00M 10-Q · filed 2024-11-01 | $184.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $27.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $90.00M 10-Q · filed 2024-08-01 | $109.00M derived: sum of 3 quarters · filed 2025-02-18 | $168.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $63.00M 10-Q · filed 2024-05-01 | $82.00M derived: sum of 2 quarters · filed 2025-02-18 | $141.00M derived: sum of 3 quarters · filed 2025-02-18 | $147.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $78.00M derived: sum of 2 quarters · filed 2025-02-18 | $84.00M derived: sum of 3 quarters · filed 2025-02-18 | $136.00M 10-K · filed 2025-02-18 |
| 2022-09-30 | $59.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $65.00M derived: sum of 2 quarters · filed 2023-11-01 | $117.00M 10-Q · filed 2023-11-01 | $125.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $58.00M 10-Q · filed 2023-08-03 | $66.00M derived: sum of 3 quarters · filed 2024-02-20 | $130.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $52.00M 10-Q · filed 2023-05-04 | $60.00M derived: sum of 2 quarters · filed 2024-02-20 | $124.00M derived: sum of 3 quarters · filed 2024-02-20 | $144.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $72.00M derived: sum of 2 quarters · filed 2024-02-20 | $92.00M derived: sum of 3 quarters · filed 2024-02-20 | $110.00M 10-K · filed 2024-02-20 |
| 2021-09-30 | $64.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $84.00M derived: sum of 2 quarters · filed 2022-11-03 | $102.00M 10-Q · filed 2022-11-03 | $106.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $38.00M 10-Q · filed 2022-08-04 | $42.00M derived: sum of 3 quarters · filed 2023-02-23 | $101.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $18.00M 10-Q · filed 2022-05-05 | $22.00M derived: sum of 2 quarters · filed 2023-02-23 | $81.00M derived: sum of 3 quarters · filed 2023-02-23 | $87.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $63.00M derived: sum of 2 quarters · filed 2023-02-23 | $69.00M derived: sum of 3 quarters · filed 2023-02-23 | $111.00M 10-K · filed 2023-02-23 |
| 2020-09-30 | $59.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $65.00M derived: sum of 2 quarters · filed 2021-11-04 | $107.00M 10-Q · filed 2021-11-04 | $117.00M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $48.00M 10-Q · filed 2021-08-06 | $58.00M derived: sum of 3 quarters · filed 2022-02-23 | $108.00M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $42.00M 10-Q · filed 2021-05-06 | $52.00M derived: sum of 2 quarters · filed 2022-02-23 | $102.00M derived: sum of 3 quarters · filed 2022-02-23 | |
| 2019-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $60.00M derived: sum of 2 quarters · filed 2022-02-23 | $123.00M 10-K · filed 2022-02-23 | |
| 2019-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $113.00M 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $63.00M 10-Q · filed 2020-08-05 | |||
| 2018-12-31 | $101.00M 10-K · filed 2021-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |